PVI
OYST

Pura Vida Investments’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History

Pura Vida Investments’s Portfolio OYST Stock Details OYST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-41,130
Closed -$751K – 312
2021
Q4 		$751K Buy
+41,130
New +$522K 0.03% 193

Other funds holding OYST

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
IFA
Invus Financial Advisors New York $89.2M AUM 10.79% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
TAM
Telemark Asset Management Boston, Massachusetts $1.38B AUM 71.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Pura Vida Investments's OYST Position: Q1 2022 in Review

Pura Vida Investments sold out of Oyster Point Pharma, Inc. Common Stock (OYST) in Q1 2022, closing a stake of 41,130 shares — an estimated $751K sold.

Pura Vida Investments first reported a position in OYST in Q4 2021 and held it in 1 quarter. The position peaked at $751K in Q4 2021. 72 funds tracked by Wall St. Rank hold OYST as of Q1 2022.

  • Pura Vida Investments reported no remaining Oyster Point Pharma, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Pura Vida Investments sold 41,130 Oyster Point Pharma, Inc. Common Stock shares in Q1 2022, an estimated $751K.
  • Pura Vida Investments first reported a position in Oyster Point Pharma, Inc. Common Stock in Q4 2021 and held it in 1 quarter.
  • Pura Vida Investments's Oyster Point Pharma, Inc. Common Stock position peaked at $751K in Q4 2021.
  • 72 funds tracked by Wall St. Rank held Oyster Point Pharma, Inc. Common Stock as of Q1 2022.

Based on Pura Vida Investments's 13F filing for Q1 2022, filed 16 May 2022.